추가 설명:
Atomoxetine, described by supplier Beijing Fengli Jingqiu Pharmaceutical Co., Ltd. as a CNS stimulant used in ADD treatment, is offered in pharmaceutical grade with documentation available in pilot quantities from an Italy-based site. The company acts as a trading distributor rather than a manufacturer, does not provide samples, and sells into markets across North America, Europe, Asia, the Middle East, and Africa.
평가 & 댓글 남기기